Parasite persistence correlates with disease severity and localization in chronic Chagas' disease
- PMID: 10395865
- DOI: 10.1086/314889
Parasite persistence correlates with disease severity and localization in chronic Chagas' disease
Abstract
The protozoan parasite Trypanosoma cruzi infects up to 20 million people in Latin America, and the resulting disease (Chagas' disease) is a leading cause of heart disease and death in young adults in areas endemic for the parasite. The clinical symptoms of Chagas' disease have been attributed to autoimmune reactivity to antigens shared by the parasite and host muscle or neuronal tissue. In the present study, in situ polymerase chain reaction analysis was used in murine models of Chagas' disease to demonstrate an absolute correlation between the persistence of parasites and the presence of disease in muscle tissue. Clearance of parasites from tissues, presumably by immunologic mechanisms, correlated with the abatement of inflammatory responses and the resolution of disease. These data provide strong evidence for parasite persistence as a primary cause of Chagas' disease and argue for efforts to eliminate T. cruzi from the host as a means for prevention and treatment of Chagas' disease.
Similar articles
-
Analysis of the presence of Trypanosoma cruzi in the heart tissue of three patients with chronic Chagas' heart disease.Am J Trop Med Hyg. 2003 Feb;68(2):242-7. Am J Trop Med Hyg. 2003. PMID: 12641419
-
American trypanosomosis: in situ and generalized features of parasitism and inflammation kinetics in a murine model.Exp Parasitol. 1996 Aug;83(3):267-74. doi: 10.1006/expr.1996.0074. Exp Parasitol. 1996. PMID: 8823243
-
Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.Mol Immunol. 2009 Mar;46(6):1092-9. doi: 10.1016/j.molimm.2008.10.034. Epub 2008 Dec 23. Mol Immunol. 2009. PMID: 19108895
-
The challenge of Chagas' disease: has the human pathogen, Trypanosoma cruzi, learned how to modulate signaling events to subvert host cells?N Biotechnol. 2010 Dec 31;27(6):837-43. doi: 10.1016/j.nbt.2010.02.003. Epub 2010 Feb 19. N Biotechnol. 2010. PMID: 20172059 Review.
-
The role of parasite persistence in pathogenesis of Chagas heart disease.Parasite Immunol. 2009 Nov;31(11):673-85. doi: 10.1111/j.1365-3024.2009.01108.x. Parasite Immunol. 2009. PMID: 19825107 Review.
Cited by
-
Evasion and Immuno-Endocrine Regulation in Parasite Infection: Two Sides of the Same Coin in Chagas Disease?Front Microbiol. 2016 May 23;7:704. doi: 10.3389/fmicb.2016.00704. eCollection 2016. Front Microbiol. 2016. PMID: 27242726 Free PMC article. Review.
-
Genes from Chagas susceptibility loci that are differentially expressed in T. cruzi-resistant mice are candidates accounting for impaired immunity.PLoS One. 2006 Dec 20;1(1):e57. doi: 10.1371/journal.pone.0000057. PLoS One. 2006. PMID: 17183687 Free PMC article.
-
Fenofibrate Increases the Population of Non-Classical Monocytes in Asymptomatic Chagas Disease Patients and Modulates Inflammatory Cytokines in PBMC.Front Cell Infect Microbiol. 2022 Mar 11;11:785166. doi: 10.3389/fcimb.2021.785166. eCollection 2021. Front Cell Infect Microbiol. 2022. PMID: 35360222 Free PMC article.
-
Oral exposure to Trypanosoma cruzi elicits a systemic CD8⁺ T cell response and protection against heterotopic challenge.Infect Immun. 2011 Aug;79(8):3397-406. doi: 10.1128/IAI.01080-10. Epub 2011 May 31. Infect Immun. 2011. PMID: 21628516 Free PMC article.
-
3-Hydroxy kynurenine treatment controls T. cruzi replication and the inflammatory pathology preventing the clinical symptoms of chronic Chagas disease.PLoS One. 2011;6(10):e26550. doi: 10.1371/journal.pone.0026550. Epub 2011 Oct 19. PLoS One. 2011. PMID: 22028903 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
